David B. MacLean — 23 Patents at Pfizer

David B. MacLean has been granted 23 US patents while listed as an inventor at Pfizer. The first was granted in 1998 and the most recent in June 2025. David B. MacLean ranks #178,160 of 4,157,543 US inventors in our database (top 4.3%). Patent records list David B. MacLean in Cambridge, MA, US.

Patents per Year

Issued Patents All Time

Showing 1–23 of 23 patents

Patent #	Title	Co-Inventors	Date	Approx Value ⓘ
12336990	Treatment of prostate cancer	Vijaykumar Rajasekhar, Brendan Mark Johnson, Lynn Seely, Paul N. Mudd, Jr., Hélène M. Faessel	2025-06-24
12144809	Treatment of prostate cancer	Vijaykumar Rajasekhar, Brendan Mark Johnson, Lynn Seely, Paul N. Mudd, Jr., Hélène M. Faessel	2024-11-19
12097198	Treatment of prostate cancer	Vijaykumar Rajasekhar, Brendan Mark Johnson, Lynn Seely, Paul N. Mudd, Jr., Hélène M. Faessel	2024-09-24
11583526	Treatment of prostate cancer	Vijaykumar Rajasekhar, Brendan Mark Johnson, Lynn Seely, Paul N. Mudd, Jr.	2023-02-21	$45,372,000
10786501	Treatment of prostate cancer	Vijaykumar Rajasekhar, Brendan Mark Johnson, Lynn Seely, Paul N. Mudd, Jr.	2020-09-29
10449191	Treatment of prostate cancer	Vijaykumar Rajasekhar, Brendan Mark Johnson, Lynn Seely, Paul N. Mudd, Jr.	2019-10-22	$6,725,000
6911456	Use of estrogen antagonists and estrogen agonists in inhibiting pathological conditions	David Thompson	2005-06-28	$179,326,000
6613796	Use of estrogen antagonists and estrogen agonists in inhibiting pathological conditions	David Thompson	2003-09-02	$632,616,000
6403611	Use of estrogen antagonists and estrogen agonists in inhibiting pathological conditions	David Thompson	2002-06-11	$237,473,000
6355670	Use of estrogen antagonists and estrogen agonists in inhibiting pathological conditions	David Thompson	2002-03-12	$439,076,000
6274618	Use of estrogen antagonists and estrogen agonists in inhibiting pathological conditions	David Thompson	2001-08-14	$1,273,352,000
6107331	Use of estrogen antagonists and estrogen agonists in inhibiting pathological conditions	David Thompson	2000-08-22	$440,456,000
6100301	Combination therapy to treat osteoporosis-polyphosphonates and estrogen agonists	David Thompson	2000-08-08	$530,149,000
6057309	Combination therapy to prevent bone loss-progesterone and estrogen agonists	David Thompson	2000-05-02	$261,390,000
6017964	Method of increasing testosterone	David Thompson	2000-01-25	$352,913,000
5985932	Inhibition of autoimmune diseases	David Thompson	1999-11-16	$304,077,000
5889042	Method of treating diseases and conditions with estrogen agonists and antagonists	David Thompson	1999-03-30	$332,124,000
5861438	Combination therapy to prevent bone loss parathyroid hormone and estrogen agonists	David Thompson	1999-01-19	$226,661,000
5773477	Combination therapy to treat osteoporosis - polyphosphonates and estrogen agonists	David Thompson	1998-06-30	$190,641,000
5733937	Methods for alleviating symptoms of premenstrual syndrome and late luteal phase dysphoric disorder	David Thompson	1998-03-31	$193,903,000
5726207	Protection of ischemic myocardium against reperfusion damage	David Thompson	1998-03-10	$213,746,000
5719191	1,1,2-triphenylbut-1-ene derivatives for treating Alzheimer's disease	David Thompson	1998-02-17	$137,227,000
5719190	Inhibition of myeloperoxidase activity	David Thompson	1998-02-17	$137,227,000

David B. MacLean — 23 Patents

Patents per Year

Issued Patents All Time

Patent Widget